Details for Patent: 7,183,264
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 7,183,264
Title: | N-pyrazole A2A receptor agonists |
Abstract: | 2-adenosine N-pyrazole compounds having the following formula: ##STR00001## and methods for using the compounds as A2A receptor agonists to stimulate mammalian coronary vasodilatation for therapeutic purposes and for purposes of imaging the heart are disclosed. |
Inventor(s): | Zablocki; Jeff (Mountain View, CA), Elzein; Elfatih O. (Fremont, CA), Palle; Venkata P. (Gurgaon, IN), Belardinelli; Luiz (Palo Alto, CA) |
Assignee: | CV Therapeutics, Inc. (Palo Alto, CA) |
Application Number: | 10/652,378 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 7,183,264
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,183,264
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 024441 | See Plans and Pricing | |||
Austria | 256141 | See Plans and Pricing | |||
Australia | 7132400 | See Plans and Pricing | |||
Australia | 760806 | See Plans and Pricing | |||
Belgium | 2011C004 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |